Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL. Husby S, Baech-Laursen C, Eskelund CW, Favero F, et al. Leukemia 2022;36:2912-2916.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Husby S, Baech-Laursen C, Eskelund CW, Favero F, et al. Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL. Leukemia 2022;36:2912-2916.
PMID: 36274067